134 related articles for article (PubMed ID: 11522652)
1. Overexpression of IRF9 confers resistance to antimicrotubule agents in breast cancer cells.
Luker KE; Pica CM; Schreiber RD; Piwnica-Worms D
Cancer Res; 2001 Sep; 61(17):6540-7. PubMed ID: 11522652
[TBL] [Abstract][Full Text] [Related]
2. cDNA microarray analysis of isogenic paclitaxel- and doxorubicin-resistant breast tumor cell lines reveals distinct drug-specific genetic signatures of resistance.
Villeneuve DJ; Hembruff SL; Veitch Z; Cecchetto M; Dew WA; Parissenti AM
Breast Cancer Res Treat; 2006 Mar; 96(1):17-39. PubMed ID: 16322897
[TBL] [Abstract][Full Text] [Related]
3. Impaired alpha-interferon signaling in transitional cell carcinoma: lack of p48 expression in 5637 cells.
Matin SF; Rackley RR; Sadhukhan PC; Kim MS; Novick AC; Bandyopadhyay SK
Cancer Res; 2001 Mar; 61(5):2261-6. PubMed ID: 11280796
[TBL] [Abstract][Full Text] [Related]
4. GBP1 overexpression is associated with a paclitaxel resistance phenotype.
Duan Z; Foster R; Brakora KA; Yusuf RZ; Seiden MV
Cancer Chemother Pharmacol; 2006 Jan; 57(1):25-33. PubMed ID: 16028104
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of c-erbB-2/neu in breast cancer cells confers increased resistance to Taxol via mdr-1-independent mechanisms.
Yu D; Liu B; Tan M; Li J; Wang SS; Hung MC
Oncogene; 1996 Sep; 13(6):1359-65. PubMed ID: 8808711
[TBL] [Abstract][Full Text] [Related]
6. Evasion of a single-step, chemotherapy-induced senescence in breast cancer cells: implications for treatment response.
Elmore LW; Di X; Dumur C; Holt SE; Gewirtz DA
Clin Cancer Res; 2005 Apr; 11(7):2637-43. PubMed ID: 15814644
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of synuclein-gamma expression increases the sensitivity of breast cancer cells to paclitaxel treatment.
Zhou Y; Inaba S; Liu J
Int J Oncol; 2006 Jul; 29(1):289-95. PubMed ID: 16773211
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus core protein modulates the interferon-induced transacting factors of Jak/Stat signaling pathway but does not affect the activation of downstream IRF-1 or 561 gene.
Basu A; Meyer K; Ray RB; Ray R
Virology; 2001 Sep; 288(2):379-90. PubMed ID: 11601909
[TBL] [Abstract][Full Text] [Related]
9. Expression of protein mediators of type I interferon signaling in human squamous cell carcinoma of the skin.
Clifford JL; Menter DG; Yang X; Walch E; Zou C; Clayman GL; Schaefer TS; El-Naggar AK; Lotan R; Lippman SM
Cancer Epidemiol Biomarkers Prev; 2000 Sep; 9(9):993-7. PubMed ID: 11008921
[TBL] [Abstract][Full Text] [Related]
10. The Jak-STAT pathway stimulated by interferon alpha or interferon beta.
Horvath CM
Sci STKE; 2004 Nov; 2004(260):tr10. PubMed ID: 15561979
[TBL] [Abstract][Full Text] [Related]
11. Glucosylceramide synthase blockade down-regulates P-glycoprotein and resensitizes multidrug-resistant breast cancer cells to anticancer drugs.
Gouazé V; Liu YY; Prickett CS; Yu JY; Giuliano AE; Cabot MC
Cancer Res; 2005 May; 65(9):3861-7. PubMed ID: 15867385
[TBL] [Abstract][Full Text] [Related]
12. Study of the effects of interferon a on several human hepatoma cell lines: analysis of the signalling pathway of the cytokine and of its effects on apoptosis and cell proliferation.
Legrand A; Vadrot N; Lardeux B; Bringuier AF; Guillot R; Feldmann G
Liver Int; 2004 Apr; 24(2):149-60. PubMed ID: 15078480
[TBL] [Abstract][Full Text] [Related]
13. A human cytomegalovirus antagonist of type I IFN-dependent signal transducer and activator of transcription signaling.
Paulus C; Krauss S; Nevels M
Proc Natl Acad Sci U S A; 2006 Mar; 103(10):3840-5. PubMed ID: 16497831
[TBL] [Abstract][Full Text] [Related]
14. Differential gene expression profiles in paclitaxel-induced cell cycle arrest and apoptosis in human breast cancer MCF-7 cells.
Wang J; He FT; Tzang CH; Fong WF; Xiao PG; Han R; Yang MS
Yao Xue Xue Bao; 2005 Dec; 40(12):1099-104. PubMed ID: 16496673
[TBL] [Abstract][Full Text] [Related]
15. Reduction in p48-ISGFgamma levels confers resistance to interferon-alpha2a in MHCC97 cells.
Wu WZ; Sun HC; Gao YQ; Li Y; Wang L; Zhou K; Liu KD; Iliakis G; Tang ZY
Oncology; 2004; 67(5-6):428-40. PubMed ID: 15714000
[TBL] [Abstract][Full Text] [Related]
16. RAIDD expression is impaired in multidrug resistant osteosarcoma cell lines.
Yang C; Hornicek FJ; Wood KB; Schwab JH; Mankin H; Duan Z
Cancer Chemother Pharmacol; 2009 Aug; 64(3):607-14. PubMed ID: 19125251
[TBL] [Abstract][Full Text] [Related]
17. Stat1-dependent induction of tumor necrosis factor-related apoptosis-inducing ligand and the cell-surface death signaling pathway by interferon beta in human cancer cells.
Choi EA; Lei H; Maron DJ; Wilson JM; Barsoum J; Fraker DL; El-Deiry WS; Spitz FR
Cancer Res; 2003 Sep; 63(17):5299-307. PubMed ID: 14500361
[TBL] [Abstract][Full Text] [Related]
18. Molecular description of evolving paclitaxel resistance in the SKOV-3 human ovarian carcinoma cell line.
Lamendola DE; Duan Z; Yusuf RZ; Seiden MV
Cancer Res; 2003 May; 63(9):2200-5. PubMed ID: 12727840
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer oestrogen independence mediated by BCAR1 or BCAR3 genes is transmitted through mechanisms distinct from the oestrogen receptor signalling pathway or the epidermal growth factor receptor signalling pathway.
Dorssers LC; van Agthoven T; Brinkman A; Veldscholte J; Smid M; Dechering KJ
Breast Cancer Res; 2005; 7(1):R82-92. PubMed ID: 15642172
[TBL] [Abstract][Full Text] [Related]
20. A hybrid IRF9-STAT2 protein recapitulates interferon-stimulated gene expression and antiviral response.
Kraus TA; Lau JF; Parisien JP; Horvath CM
J Biol Chem; 2003 Apr; 278(15):13033-8. PubMed ID: 12574168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
